News 2024-12-19
Porton Newsletter | Q4 2024 Recap
Porton Expands GMP Manufacturing and New Modality Services in Shanghai Fengxian
Porton Successfully Hosts Ceremony for New Modality Capacity UpgradeDrug Modalities: Innovative Services & Solutions from Porton Pharma
Click to Download
Others
More
News 2025-06-20
Porton Shanghai Pudong R&D and Manufacturing Site Has Passed the EU QP Audit
Porton Pharma Solutions Ltd. (hereinafter “Porton”) is glad to announce that its Shanghai Pudong R&D and Manufacturing Site has passed the EU Qualified Person (QP) audit.
News 2025-06-19
Porton Shanghai Fengxian Manufacturing Site Has Passed the EU QP Audit
The successful completion of the QP audit is a recognition of the quality management system of Shanghai Fengxian Manufacturing Site, demonstrating Porton's commitment to practicing high standard quality management. It marks that Shanghai Fengxian Manufacturing Site can provide CDMO services for small molecules, peptides and oligonucleotides, proteins and conjugate drugs that meet international standards to global customers.
